1). 88% Buy, up from 72% buy last week and 40% Buy, a month ago @Barchart.
2). Stay Long @ American Bulls.
3). $10.75 Price Target, from 5 analysts @Barrons.
4). $4.00 >$11.50 > $16.00 Price Targets @CNN Business.
5). HOLD Rating @ Zacks.
6). $11.22 TP mean rating, Chartmill.
Recent PYXS News
- Pyxis Oncology to Present at the RBC Capital Markets Global Healthcare Conference • GlobeNewswire Inc. • 05/09/2024 11:30:00 AM
- Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 03/28/2024 08:30:00 PM
- Pyxis Oncology Obtains $8 Million Payment for the Sale of Royalty Rights • GlobeNewswire Inc. • 03/27/2024 11:30:00 AM
- Pyxis Oncology Provides Corporate Update and Reports Financial Results for Fourth Quarter and Full Year 2023 • GlobeNewswire Inc. • 03/21/2024 11:30:00 AM
- Pyxis Oncology Expands Board of Directors with Appointment of Santhosh Palani, Ph.D., CFA • GlobeNewswire Inc. • 03/13/2024 12:00:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 03/08/2024 09:03:18 PM
- Pyxis Oncology to Present at Leerink Global Biopharma Conference 2024 • GlobeNewswire Inc. • 03/07/2024 09:30:00 PM
- Pyxis Oncology to Present New PYX-201, PYX-106 and PYX-102 Preclinical Data at AACR Annual Meeting • GlobeNewswire Inc. • 03/05/2024 09:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 12:02:43 PM
- Pyxis Oncology Announces $50 Million Private Placement • GlobeNewswire Inc. • 02/27/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 09:33:36 PM
- Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 12/29/2023 09:30:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 12/06/2023 09:50:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/30/2023 09:15:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/28/2023 12:22:15 PM
- Pyxis Oncology Announces Appointment of Ken Kobayashi, M.D., F.A.C.P as Chief Medical Officer • GlobeNewswire Inc. • 11/28/2023 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/17/2023 09:16:45 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2023 09:46:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2023 09:44:14 PM
- Pyxis Oncology Announces Initiatives to Prioritize Lead ADC Program; Reports Financial Results for Third-Quarter 2023 and Provides Corporate Update • GlobeNewswire Inc. • 11/07/2023 09:30:00 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 10/27/2023 08:34:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/28/2023 08:32:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/27/2023 10:37:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/27/2023 10:36:38 PM
- Pyxis Oncology Announces Four Abstracts Accepted for Poster Presentation at Society for Immunotherapy of Cancer (SITC) 2023 • GlobeNewswire Inc. • 09/27/2023 01:18:58 PM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM